Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

HPV infection and cervical neoplasia: associated risk factors (2015)

  • Authors:
  • USP affiliated authors: VILLA, LUISA LINA - FM
  • USP Schools: FM
  • DOI: 10.1186/s13027-015-0011-3
  • Subjects: NEOPLASIAS DOS GENITAIS FEMININOS (DIAGNÓSTICO); PREVALÊNCIA; FATORES DE RISCO; HPV (COMPLICAÇÕES)
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/s13027-015-0011-3 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1186/s13027-015-0011-3 (Fonte: Unpaywall API)

    Título do periódico: Infectious Agents and Cancer

    ISSN: 1750-9378

    • Melhor URL em Acesso Aberto:


    • Outras alternativas de URLs em Acesso Aberto:


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: Infectious Agents and Cancer

    ISSN: 1750-9378

    Citescore - 2017: 2.21

    SJR - 2017: 0.855

    SNIP - 2017: 0.979


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2755603-10BCSEP^543^2015
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RIBEIRO, Andrea Alves; COSTA, Maria Cecília; ALVES, Rosane Ribeiro Figueiredo; et al. HPV infection and cervical neoplasia: associated risk factors. Infectious Agents and Cancer, London, v. 10, n. 16, p. 7 , 2015. Disponível em: < http://infectagentscancer.biomedcentral.com/articles/10.1186/s13027-015-0011-3 > DOI: 10.1186/s13027-015-0011-3.
    • APA

      Ribeiro, A. A., Costa, M. C., Alves, R. R. F., Villa, L. L., Saddi, V. A., Carneiro, M. A. dos S., et al. (2015). HPV infection and cervical neoplasia: associated risk factors. Infectious Agents and Cancer, 10( 16), 7 . doi:10.1186/s13027-015-0011-3
    • NLM

      Ribeiro AA, Costa MC, Alves RRF, Villa LL, Saddi VA, Carneiro MA dos S, Zeferino Luiz Carlos, Rabelo-Santos SH. HPV infection and cervical neoplasia: associated risk factors [Internet]. Infectious Agents and Cancer. 2015 ; 10( 16): 7 .Available from: http://infectagentscancer.biomedcentral.com/articles/10.1186/s13027-015-0011-3
    • Vancouver

      Ribeiro AA, Costa MC, Alves RRF, Villa LL, Saddi VA, Carneiro MA dos S, Zeferino Luiz Carlos, Rabelo-Santos SH. HPV infection and cervical neoplasia: associated risk factors [Internet]. Infectious Agents and Cancer. 2015 ; 10( 16): 7 .Available from: http://infectagentscancer.biomedcentral.com/articles/10.1186/s13027-015-0011-3

    Referências citadas na obra
    Hoory T, Monie A, Gravitt P, Wu TC. Molecular epidemiology of human papillomavirus. J Formos Med Assoc. 2008;107:198–217.
    Lenselink CH, Melchers WJG, Quint WGV, Hoebers AMJ, Hendriks JCM, Massuger LFAG, et al. Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands. PLoS One. 2008;3, e3743.
    Muñoz N, Bosch FX, de Sanjosé S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52:743–9.
    Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.
    Dempsey AF, Mendez D. Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate. J Adolesc Health. 2010;47:242–8.
    Moscicki AB, Ma Y, Wibbelsman C, Powers A, Darragh TM, Farhat S, et al. Risks for cervical intraepithelial neoplasia-3 among adolescents and young women with abnormal cytology. Obstet Gynecol. 2008;112:1335–42.
    Hwang LY, Ma Y, Benningfield SM, Clayton L, Hanson EN, Jay J, et al. Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health. 2009;44:103.
    Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine. 2008;11:16–36.
    Ragin CC, Watt A, Markovic N, Bunker CH, Edwards RP, Eckstein S, et al. Compararisons of high-risk cervical HPV infections in Caribean and US populations. Infect Agent Cancer. 2008;4:1–7.
    Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev. 2006;15:2148–53.
    Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB, Johansson BC, et al. Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study. Cancer Epidemiol Biomarkers Prev. 2007;16:17–22.
    Zeferino LC, Derchain SF. Cervical cancer in the developing world. Best Pract Res Clin Obstet Gynaecol. 2006;20:339–54.
    Ribeiro AA, Figueiredo Alves RR, Costa MC, Villa LL, Zeferino LC, Mauricette Derchain SF, et al. Association between HPV types and species groups and cervical neoplasia from a high-risk area for cervical cancer, Goiânia, Brazil. Int J Gynecol Pathol. 2011;30:288–94.
    Internation Agency for Research on Cancer (IARC). A review of human carcinogens — PartB: biological agents. Monographs on the evaluation of carcinogenic risks to humans. 2012;100B:267-295.
    Steenbergen RDM, Snijders PJF, Heideman DAM, Meijer CJLM. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14:395–405.
    Scully RE, Bonfiglio TA, Kurman RJ. Histological typing of female genital tract tumors. In: World Health Organization. International Classification of Tumors. 2nd ed. Berlin: Springer; 1994. p. 36–49.
    Widdice LE, Moscicki AB. Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. J Adolesc Health. 2008;43:41–51.
    Harris RW, Brinton LA, Cowdell RH, Skegg DC, Smith PG, Vessey MP, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer. 1980;42:359–69.
    Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodríguez AC, Bratti MC, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res. 2006;66:1218–24.
    Almonte M, Ferreccio C, Gonzales M, Delgado JM, Buckley CH, Luciani S, et al. Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Int J Gynecol Cancer. 2011;21:1654–63.
    Mosciscki AB. HPV infections in adolescents. Dis Markers. 2007;23:229–34.
    Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behaviour in context: a global perspective. Lancet. 2006;368:1706–28.
    Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006;208:152–64.
    Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer. 2004;91:942–53.
    Mazarico E, Gonzalez-Bosquet E. Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology. Gynecol Oncol. 2012;125:181–5.
    Baandrup L, Munk C, Andersen KK, Junge J, Iftner T, Kjær SK. HPV 16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3. Gynecol Oncol. 2012;124:281–5.
    Flores YN, Bishai DM, Shah KV, Lazcano-Ponce E, Lörincz A, Hernández M, et al. Risk factors for cervical cancer among HPV positive women in Mexico. Salud Publica Mex. 2008;50:49–58.
    Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103:368–83.
    Cercato MC, Mariani L, Vocaturo A, Carrone A, Terrenato I, Morano G, et al. Predictors of human papilloma virus (HPV) infection in Italian women. J Med Virol. 2010;82:1921–7.
    Sarian LO, Hammes LS, Longatto-Filho A, Guarisi R, Derchain SF, Roteli-Martins C, et al. Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study. Sex Transm Dis. 2009;36:241–8.
    Yetimalar H, Kasap B, Cukurova K, Yildiz A, Keklik A, Soylu F. Cofactors in human papillomavirus infection and cervical carcinogenesis. Arch Gynecol Obstet. 2012;285:805–10.